3 results
Approved WMORecruitment stopped
To assess if the *BasIQ* makes a standardized incision of 4 cm.
Approved WMOCompleted
Primary objective is assessment of the pharmacokinetic profile of MPD in pregnancy. Secondary objectives are the safety and efficacy of any use of MPD during pregnancy.
Approved WMORecruitment stopped
Primary objectives: The main objective of this Post Market Clinical Follow-Up (PMCF) study is to further evaluate and monitor the safety and performance of the *BasIQ-4®* in a population of women delivering in general hospitals in The Netherlands…